Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

213.13 +5.13 (+2.47%)
Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
40 41 Next >
News headline image
Got $3,000? 2 Artificial Intelligence (AI) Stocks to Buy and Hold for the Long Term ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Deep Dive Into Illumina Stock: Analyst Perspectives (14 Ratings) ↗
 
Via Benzinga
News headline image
Apple To $250? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
How Do Investors Really Feel About Illumina? ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Demystifying Illumina: Insights From 11 Analyst Reviews ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
3 Mid-Cap Stocks Walking a Fine Line
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
News headline image
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
The Future of the Military: 10 Predictions for the Next Decade
The military landscape has always been a dynamic arena, shaped by technological advancements, geopolitical shifts, and evolving threats. As we stand in 2025, the world is on the cusp of transformative... 
Via MarketMinute
Topics Artificial Intelligence Climate Change Energy
News headline image
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain ↗
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
News headline image
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen ↗
Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV. 
Via Benzinga
News headline image
Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock ↗
Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and Arista Networks. 
Via Benzinga
News headline image
Why Illumina Stock Got Mashed on Monday ↗
Via The Motley Fool
News headline image
Nvidia Stock Reached All-Time Highs After Jensen Huang's CES Keynote — Will Next Week's GTC Spark Another Surge? ↗
Jensen Huang will give a keynote speech at Nvidia's GTC conference next week. A keynote from Huang at CES earlier this year took Nvidia stock to highs. 
Via Benzinga
News headline image
Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes ↗
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China sales recovering faster than expected. 
Via Benzinga
News headline image
Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions ↗
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for high-single-digit growth by 2027. 
Via Benzinga
News headline image
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation. 
Via StockStory
News headline image
Illumina Stock Slammed As China Retaliates Against Trump's Tariffs ↗
The company's gene-mapping products are now banned from import in China amid the escalating trade war between the U.S. and China. 
Via Investor's Business Daily
Topics Government World Trade
News headline image
US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War ↗
China banned imports of Illumina's gene sequencers as new U.S. tariffs took effect, cutting its market access while Chinese rivals gain ground in the biotech sector. 
Via Benzinga
Topics World Trade
News headline image
GenoFAB Launches Hybrid Plasmid Sequencing Service To Set a New Standard for Reproducibility in Biotechnology
Via Get News
News headline image
Biotech Stocks Had A Good Week Despite Crosscurrents ↗
It’s too early to account for the rally but in general one can say that there is a lot of speculation from both the retail side and hedge funds. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15 ↗
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Feb. 10-14, 2025. 
Via Talk Markets
Topics Stocks / Equities
News headline image
PacBio (PACB) Q4 Earnings Report Preview: What To Look For
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market hours. Here’s what investors should know. 
Via StockStory
News headline image
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 
Via StockStory
News headline image
Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs ↗
On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company. 
Via Benzinga
News headline image
Why Illumina (ILMN) Stock Is Trading Lower Today
Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded the stock to Sell and lowered the price target from $130 to $100. The firm cited several... 
Via StockStory
News headline image
This Illumina Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday ↗
 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.